Buprenorphine Transdermal and Daclizumab Subcutaneous
Determining the interaction of Buprenorphine Transdermal and Daclizumab Subcutaneous and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: buprenorphine
Brand name: Probuphine, Belbuca, Buprenex, Butrans, Sublocade, Subutex
Synonyms: Buprenorphine (implant), Buprenorphine
Generic Name: daclizumab
Brand name: Zinbryta, Zenapax
Synonyms: Daclizumab
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Buprenorphine Transdermal-Dacogen
- Buprenorphine Transdermal-Dacomitinib
- Buprenorphine Transdermal-Dactinomycin
- Buprenorphine Transdermal-Dactinomycin Injection
- Buprenorphine Transdermal-Dactinomycin Intravenous
- Buprenorphine Transdermal-Daklinza
- Daclizumab Subcutaneous-Buprenorphine Transdermal Patch
- Daclizumab Subcutaneous-Buprenorphine transdermal skin patch
- Daclizumab Subcutaneous-Buprenorphine, Buprenorphine Hydrochloride
- Daclizumab Subcutaneous-Buprenorphine/naloxone Oromucosal, Sublingual
- Daclizumab Subcutaneous-Buproban
- Daclizumab Subcutaneous-Bupropion